Autoimmune rheumatologic diseases

Oral Abstract Session

Distinct Single Cell Gene Expression Signatures of Monocyte Subsets Differentiate Between TNF-Alpha Inhibitor Treatment Response Groups in Rheumatoid Arthritis

Friday, June 16
4:15 PM - 4:30 PM

Work from our group demonstrated that pre-treatment serum type I IFN-β/α ratio>1.3 predicts non-response to anti-TNFα therapy (TNFi) in RA patients. Mechanisms that underlie the IFN-β/α ratio that predicts response are unknown. Effects of IFN on uncommon cell populations may be masked in whole blood or mixed cell populations. We used single cell analysis to investigate whether monocyte gene expression differs significantly between RA patients according to their pre-TNFi serum IFN-β/α ratio. Single classical (CL) and non-classical (NC) blood-derived monocytes were isolated from seropositive RA subjects prior to biologic therapy. Subjects were grouped by pre-TNFi serum IFN-β/α ratio: IFN-β/α>1.3(n=6) and IFN-β/αJAK1,IL1A,TLR2,CD32A,CD36, CXCR3,IL8,IRAK1, and TYK2 expression were retained in the mixed monocyte gene expression model for differentiating between groups. JAK1 and IL1A were also retained in the models from monocyte subsets.TLR9,STAT1, and FCER were retained in the CL model. STAT2 and IFI27 were retained in the NC model. Regression models from the monocyte subsets provided increased discriminatory potential in comparison to the mixed monocyte model. Within-cell co-expression patterns demonstrate biological differences in monocyte subsets of RA patients with an IFN-β/α>1.3, the ratio of type I IFNs which predicts non-response to TNFi.When monocyte subsets were analyzed separately, differentiation by gene expression was strongest and distinct expression signatures were identified, suggesting that further study of monocyte subsets will illuminate molecular differences that determine treatment response to TNFi in RA.

Theresa Wampler Muskardin

Assistant Professor
Mayo Clinic, Department of Medicine and Department of Pediatrics and Adolescent Medicine, Division of Rheumatology

Presentation(s):

Send Email for Theresa Wampler Muskardin

Wei Fan

Department of Rheumatology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University

Presentation(s):

Send Email for Wei Fan

Send Email for Zhongbo Jin

Mark Jensen

Department of Immunology and Division of Rheumatology, Mayo Clinic

Presentation(s):

Send Email for Mark Jensen

Jessica Dorschner

Department of Immunology and Division of Rheumatology, Mayo Clinic

Presentation(s):

Send Email for Jessica Dorschner

Yogita Ghodke-Puranik

Assistant Professor
Department of Immunology and Division of Rheumatology, Mayo Clinic

Presentation(s):

Send Email for Yogita Ghodke-Puranik

Betty Ann Dicke

Mayo Clinic, Department of Medicine, Division of Rheumatology

Presentation(s):

Send Email for Betty Ann Dicke

Danielle Vsetecka

Mayo Clinic, Department of Medicine, Division of Rheumatology

Presentation(s):

Send Email for Danielle Vsetecka

Mayo Clinic Inflammatory Arthritis Clinic Group

Mayo Clinic, Department of Medicine, Division of Rheumatology

Presentation(s):

Send Email for Mayo Clinic Inflammatory Arthritis Clinic Group

Timothy Niewold

Associate Professor
Department of Immunology and Division of Rheumatology, Mayo Clinic

Presentation(s):

Send Email for Timothy Niewold


Assets

Distinct Single Cell Gene Expression Signatures of Monocyte Subsets Differentiate Between TNF-Alpha Inhibitor Treatment Response Groups in Rheumatoid Arthritis



Attendees who have favorited this

Send Email for Distinct Single Cell Gene Expression Signatures of Monocyte Subsets Differentiate Between TNF-Alpha Inhibitor Treatment Response Groups in Rheumatoid Arthritis